Siegfried Group is a leading independent provider of custom process development, scale-up and commercial manufacture of active pharmaceutical ingredients and advanced pharmaceutical intermediates as well as a manufacturer of non-patented standard APIs with its manufacturing capacities being located in Switzerland and the United States.

In addition, Siegfried is not only a recognized developer of dossier for and supplier of drug products with development and manufacutring capacities in Switzerland and Malta but also a provider of challenging contract development  and contract manufacturing of solid applications  and a range of related services.

The Siegfried Group is a worldwide life science company with production sites in Switzerland, Malta and the U.S. and an office in China.

Siegfried offers for drug products: contract manufacturing of oral solida, contract development of complex formulation (all forms) and portfolio of drug product under its own IP for licensing out . For drug substance: a wide opiate portfolio developed under its own IP as well as custom process development, scale-up and commercial manufacturing  of APIs and advanced pahrmaceutical intermediates.